Evidence Lacking To Assess Added Dense-Breast, 3-D Mammo Cancer Screens, Task Force Says
This article was originally published in The Gray Sheet
Executive Summary
In a draft recommendation, the U.S. Preventive Services Task Force says evidence is "insufficient" to assess 3D tomosynthesis for breast cancer screening, as well as for additional dense-breast screening by any modality.